Osteosarcoma: Current Treatment and a Collaborative Pathway to Success - Test2 - elhamkhani - TriplyDB

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

http://www.wikidata.org/entity/Q26797555

about

Advances in the management of osteosarcoma T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities Review of Osteosarcoma and Current Management AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective study Vascularized Fibula-Based Physis Transfer: A Follow-Up Study of Longitudinal Bone Growth and Complications A Kinase-Independent Role for Cyclin-Dependent Kinase 19 in p53 Response.Treatment pathway of bone sarcoma in children, adolescents, and young adults JNK pathway mediates curcumin-induced apoptosis and autophagy in osteosarcoma MG63 cells.Transcription Factor 21 (TCF21) rs12190287 Polymorphism is Associated with Osteosarcoma Risk and Outcomes in East Chinese Population A review and outlook in the treatment of osteosarcoma and other deep tumors with photodynamic therapy: from basic to deep.Serum CEACAM1 Level Is Associated with Diagnosis and Prognosis in Patients with Osteosarcoma Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion.Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.Apoptosis and autophagy induced by pyropheophorbide-α methyl ester-mediated photodynamic therapy in human osteosarcoma MG-63 cells.Bridging translation for acute kidney injury with better preclinical modeling of human disease Ezrin Inhibition Up-regulates Stress Response Gene Expression Deciphering signaling networks in osteosarcoma pathobiology.Long noncoding RNA ANRIL is activated by hypoxia-inducible factor-1α and promotes osteosarcoma cell invasion and suppresses cell apoptosis upon hypoxia CX-5461 induces autophagy and inhibits tumor growth via mammalian target of rapamycin-related signaling pathways in osteosarcoma IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα Co-delivery of doxorubicin and recombinant plasmid pHSP70-Plk1-shRNA by bacterial magnetosomes for osteosarcoma therapy.Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential.Ras-Association Domain Family 1 Isoform A (RASSF1A) Gene Polymorphism rs1989839 is Associated with Risk and Metastatic Potential of Osteosarcoma in Young Chinese Individuals: A Multi-Center, Case-Control Study.Economic independence in survivors of cancer diagnosed at a young age: A Norwegian national cohort study.The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells.Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance.FOXC2 augments tumor propagation and metastasis in osteosarcoma.Celastrol increases osteosarcoma cell lysis by γδ T cells through up-regulation of death receptors.A review of the mechanism of action and clinical applications of sorafenib in advanced osteosarcoma.Downregulation of BZW2 inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway.Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition.SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway.Childhood osteosarcoma: Incidence and survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA Network 2000-2013.

P2860

Q28067644-E427EFE6-DBAA-4366-8C74-4000458D265B Q28074619-91236237-FCF8-42C1-80EA-2335D0B64030 Q28077590-B4149327-44B7-45FF-9421-DA127E7179F8 Q28079708-A339032E-CFF3-40D4-AF33-D6E28B2EC731 Q28550430-88D486C8-4F0A-4136-A579-9EB98E8923F3 Q28553450-876D499E-1030-46BB-8876-981E191E3C84 Q33715651-0F38D6A5-E423-43A3-8A45-0C4239C60C17 Q33758207-9B76606C-B256-420F-979D-85D5A969A831 Q33765368-C52CA9FD-4A76-4050-8F34-CE2C2FA1B317 Q33804888-84B6B975-2D2E-48E8-97A3-A1ED3088BA46 Q33835657-ECAF2F21-E670-4604-83F6-31AB86FD580F Q33846456-1B02B75A-7D3D-40BA-A67B-72A923ED0F20 Q33888122-D6F37C2C-F629-4E2E-B61F-480A72FEE360 Q33889409-B842405C-C9F9-4D13-BFBD-41D4DBBD7089 Q35988462-724F4909-40C2-493C-910C-725CEB2F1FA4 Q36194212-6E88F36E-026F-4529-B503-CCB19675DCC6 Q36203931-F818AC62-AC2E-47ED-AE4B-3C69E048DF4B Q36256343-C10B929C-E74A-45C0-B43E-01D410C6C09D Q36859217-F63DDDEF-79B4-4C7D-B1D0-4DCFC5A071A6 Q36957116-1E5C90C6-23B3-4C7B-8A90-5EFF816F1874 Q37065917-5B750733-0349-4D79-89C6-6A06EA5DA31F Q37106930-68780C8C-4A9E-41E2-9B57-40EAC5F0F150 Q37280716-FEB00742-A2C7-408D-BD2D-6FD359723A6C Q37306002-873229F8-8F61-405F-A1BC-6FBF30EBF537 Q37376164-7FDE4012-05F1-4F61-BA8D-E9C18810230C Q37381487-C9B06D24-3CFA-4941-94F1-DBE6E74924DA Q37437481-C5294A47-6C8B-48E2-B94B-124617E22876 Q37462883-8CE36062-8310-4558-B55D-9023272500A5 Q37505604-FAD9AF3D-4A50-4841-B9D1-43D7FE9435E0 Q37553760-3CAF9F0C-CC3A-43F3-BCD6-1D9C7FF585F0 Q37604370-F86FAD8D-2DDE-47C6-A919-8B0BB84F4841 Q37662370-5383C569-273D-4709-9D21-73A6B010D5C8 Q37688620-3115E0BD-F1EC-409B-8928-07A22451AFB6 Q37708856-863A6417-84FB-4216-9B7F-CC9DACE8AFAF Q37708954-1BEA462A-C5C0-4F0C-97B9-64D0605FCF87 Q38614928-FFC7B56E-DBB4-4480-A3D6-A1294349C5B5 Q38632877-391F28FF-942D-452E-AB84-A3703E044E9F Q38707939-441B9039-2DBA-4A03-9B22-047E380259CC Q38710096-DC2F21AA-7FBC-4940-A4AC-69F10FC67DDB Q38730393-0C927F0D-7D59-4C1B-8BDF-773C1F97DD2F

P2860

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

http://www.wikidata.org/entity/Q26797555

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

@ast

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

@en

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

@nl

type

label

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

@ast

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

@en

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

@nl

prefLabel

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

@ast

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

@en

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

@nl

P1433

Q26797555-B0006E47-8A27-45F0-A0FE-2CE2E2631F79

P1476

Q26797555-8740F7A2-573C-47FF-A156-23C4BD8A1583

P2093

Q26797555-241A8026-4C32-4C6C-AC92-9E9FCC1BF2D7

Q26797555-26647CD4-0713-4797-B075-460A6849C1B4

Q26797555-59ACF39F-7CF2-4308-BF32-173D236C2957

P2860

Q26797555-0B1F9E9E-FAA8-4D3B-980F-05373DC993C6

Q26797555-10D5C25B-65D0-4E84-865F-E503E0C48FDD

Q26797555-129128C9-3912-4697-B0A6-EB3D09F10706

Q26797555-1312E96B-C4BA-4E91-BA20-0274C334FFCF

Q26797555-18B37B1A-E464-4588-BC66-BC78FF59A260

Q26797555-1B69FD1F-51E0-44A0-86E3-4BC9A56AE795

Q26797555-2934E9BB-B3CD-4271-BC31-6A89E9DEFD34

Q26797555-2C9EB239-6CBB-4B56-8838-AF969C4C5BD8

Q26797555-4A32C4E8-7133-4A57-AF51-8C195DD54E6C

Q26797555-4DAD9AF6-DC20-4F1C-8EF3-85CA10332F83

P304

Q26797555-A56C1C67-7D24-47CB-9730-6E9064EE41C3

P31

Q26797555-66BDA1EB-DA74-4749-A221-5F5CEF516444

P3181

Q26797555-22999902-0119-4793-96ED-182E6856A516

P356

Q26797555-5CAECB9E-26BB-41E1-A827-F93F154A3366

P407

Q26797555-19563A25-C671-46BB-97E5-B5F12952C802

P433

Q26797555-B6FD43E5-2182-43EB-B0B7-75F55BF28A03

P478

Q26797555-BB4EA6F0-5987-43A9-9EA7-C34FE4C761A9

P50

Q26797555-AF90DEF1-A09F-4AB3-A616-5EBD257B4F03

P577

Q26797555-D13895BC-7807-495F-91D3-EA9F1671575F

P698

Q26797555-BE8E9AFF-5C4F-48F5-9E03-3066CFCC0C9A

P921

Q26797555-6BD64093-E5BD-42E9-A2B8-76A5E8188DFF

P932

Q26797555-3B13A53F-8334-4915-B04C-507524602322

P3181

P356

JCO.2014.59.4895

P1433

Journal of Clinical Oncology

P1476

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

@en

P2093

Michael S Isakoff

http://www.w3.org/2001/XMLSchema#string

Paul Meltzer

http://www.w3.org/2001/XMLSchema#string

Stefan S Bielack

http://www.w3.org/2001/XMLSchema#string

P2860

Children's Oncology Group's 2013 blueprint for research: bone tumors

Genome-wide association study identifies two susceptibility loci for osteosarcoma

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good R

A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study

Phase II study of ifosfamide as a single drug for relapsed paediatric patients.

Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.

Outcomes for children and adolescents with cancer: challenges for the twenty-first century.

Toward a drug development path that targets metastatic progression in osteosarcoma.

P304

3029-3035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2126239

http://www.w3.org/2001/XMLSchema#string

P356

10.1200/JCO.2014.59.4895

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Richard G Gorlick

P577

2015-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26304877

http://www.w3.org/2001/XMLSchema#string

P921

P932

4979196

http://www.w3.org/2001/XMLSchema#string